1. Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC). (December 2016) Authors: Necchi, A.; Fina, E.; Giannatempo, P.; Colecchia, M.; Raggi, D.; Daidone, M.G.; Cappelletti, V. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Extracellular matrix proteins derived from the tumor microenvironment as circulating breast cancer diagnostic markers. (July 2016) Authors: Giussani, M.; Landoni, E.; Merlino, G.; Turdo, F.; Veneroni, S.; Cappelletti, V.; Daidone, M.G.; Miceli, R.; Orlandi, R.; Triulzi, T.; Tagliabue, E. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial. Issue 2 (1st February 2021) Authors: Mennitto, A.; Verzoni, E.; Cognetti, F.; Miceli, R.; Milella, M.; Mosca, A.; Chiuri, V. E.; Bearz, A.; Morelli, F.; Ortega, C.; Atzori, F.; Donini, M.; Claps, M.; Guadalupi, V.; Sepe, P.; Cappelletti, V.; de Braud, F. G.; Procopio, G. Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 2(2021) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗